4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-025761
Chief Discovery Officer sold 31,515 shares at $13.88 ($437,428)
- Chief Discovery Officer acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Babu Yarlagadda S · Chief Discovery Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-14 | Exercise or conversion : show line 1 in the form | +50,000 | $1.42 | $71,000 | 280,056 | D |
| 2022-11-14 | Exercise or conversion : show line 2 in the form | +50,000 | $1.42 | $71,000 | 330,056 | D |
| 2022-11-14 | Sale : show line 3 in the form | −31,515 | $13.88 | $437,428 | 298,541 | D |
| Open-market sales · 31,515 sh · avg $13.88 · $437,428 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-11-14 | Exercise or conversion : show line 4 in the form Emp. Stock Option (Right to Buy) | −50,000 | 0 | D |
| 2022-11-14 | Exercise or conversion : show line 5 in the form Emp. Stock Option (Right to Buy) | −50,000 | 0 | D |
Loading xslF345X03/form4.xml…